Form 4 for TKR TIMKEN CO
Accepted 2022-11-15 00:00:00 ET · period of report 2022-11-14 · accession 0000098362-22-000125 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-15 | 2022-11-14 | TKR | Kyle Richard G | Pres, CEO, Dir | M - OptEx | $45.35 | +20.0K | 359.8K | +6% | +$907.0K |
| D | 2022-11-15 | 2022-11-14 | TKR | Kyle Richard G | Pres, CEO, Dir | F - Tax | $74.09 | -3,324 | 356.5K | -0.9% | -$246.3K |
| D | 2022-11-15 | 2022-11-14 | TKR | Kyle Richard G | Pres, CEO, Dir | S - Sale+OE | $74.03 | -16.7K | 339.8K | -5% | -$1.23M |
| D | 2022-11-15 | 2022-11-14 | TKR | Kyle Richard G | Pres, CEO, Dir | M - OptEx | $0.00 | -20.0K | 40.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-14 | M | A | 20,000 | $45.35 | 359,843 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-14 | F | D | 3,324 | $74.09 | 356,519 | D | — | — | |
| 3 | Common | Common Stock | 2022-11-14 | S | D | 16,676 | $74.03 | 339,843 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $73.72 to $74.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2022-11-14 | M | D | 20,000 | $0.00 | 40,000 | D | $45.35 · 2018-02-13 to 2027-02-13 | 20,000 Common Stock | (F2) 20,000 stock options from 2/13/2017 grant of 117,750 stock options (previously reported) that vested in 25% increments per year from the date of grant. |